WHAT YOU ARE TOLD
Injectable medicines influence appetite and blood-sugar pathways.
Time: Long-term treatment
Cost: Often high
THE REAL COST OF WEIGHT LOSS™
Medical optionGLP-1 / GIP Injections
Injectable medicines influence appetite and blood-sugar pathways.
WHAT DAILY LIFE MAY ACTUALLY INVOLVE
The method can grow legs.
Dose escalation, monitoring and ongoing access are important.
- Check eligibility
- Arrange consultation
- Pay for or collect treatment
- Follow dose escalation
- Attend monitoring
- Adapt food and activity
- Manage side effects
- Plan what happens if treatment stops
BUILD YOUR OWN ESTIMATE
See what this choice could ask from your life.
Change every figure. Defaults are illustrative planning assumptions, not universal facts.
Weekly time0
Annual time0
Annual spending£0
Three-year time0
Three-year spending£0
Personal estimate from the figures entered. It excludes the value of your time and any unentered costs.
EVIDENCE & SAFETY — LAST REVIEWED 6 AUGUST 2026
Important information to discuss with a qualified prescriber
These medicines can be beneficial and appropriate for some people, but they are prescription treatments with recognised risks, monitoring needs and practical considerations. This information supports informed decisions and does not replace individual medical advice.
Acute pancreatitis warnings strengthened
The MHRA strengthened warnings for GLP-1 and dual GLP-1/GIP medicines following rare severe cases of acute pancreatitis, including necrotising and fatal cases. Severe, persistent abdominal pain—sometimes radiating to the back, with or without nausea or vomiting—requires urgent medical attention.
Read the official MHRA warningVery rare semaglutide-associated NAION eyesight risk
The MHRA updated semaglutide information to include a very rare risk of non-arteritic anterior ischaemic optic neuropathy (NAION), which can cause sudden, painless deterioration or loss of vision, usually in one eye. Sudden or rapidly worsening vision requires urgent assessment.
Read the official MHRA eye-safety updateTell the clinical team before an operation
GLP-1 medicines slow stomach emptying. The MHRA advises patients to tell the healthcare team before surgery or deep sedation because anaesthetic instructions or techniques may need to be adjusted. Prescribed treatment should not be stopped without medical advice.
Pregnancy restrictions and Mounjaro contraceptive advice
The MHRA says GLP-1 medicines should not be used during pregnancy, while trying to become pregnant or while breastfeeding. People using oral contraception with Mounjaro should discuss additional or alternative contraception after starting treatment and following dose increases.
Suspected reports do not prove causation
The Yellow Card Scheme helps regulators identify possible safety signals. A report may involve a serious outcome, but a report alone does not prove that a medicine caused the event. Regulators assess reports alongside clinical and exposure data.
Use a legitimate prescription and regulated supplier
The MHRA warns against illegal or falsified weight-loss medicines sold online. Such products may contain incorrect ingredients, wrong strengths or unsafe contaminants.
Balanced context:
These warnings do not mean every patient will experience these problems or that the medicines are unsuitable for everyone. They mean that people deserve proper assessment, genuine medicines, appropriate monitoring and a clear discussion of benefits and risks before treatment starts.
POTENTIAL BENEFITS
Why people may choose it.
Substantial average weight loss in eligible patients.
LIMITATIONS & CONSIDERATIONS
What deserves a closer look.
GI side effects, contraindications, lean-mass loss, cost and regain after stopping.
BEFORE YOU COMMIT
Questions worth asking.
- What is the full cost over 3, 6 and 12 months?
- How much time will shopping, preparation, tracking, meetings, travel or exercise take?
- What restrictions affect restaurants, work, holidays and family life?
- What happens when I stop?
- What support, products or treatment may still be required later?
THE YOUNGER REFLECTIONS DIFFERENCE
Designed around a defined journey and independence.
Three programme payments rather than an indefinite weight-loss subscription.
No permanent logging or macro calculation in the core programme.
The protected programme focuses first on weight-management education and mindset.
The Body Intelligence experience is the single public route into the Everyday Health Library™ and Health Zappers.
Important: General consumer education only. Suitability, outcomes, risks and costs vary. Medical, injection and surgical options require appropriately qualified clinical advice.